CMS: Medicare beneficiaries saved $3.9B on meds in 2013

CMS: medicare beneficiaries saved $3.9B on meds in 2013

(HealthDay)—In 2013, 4.3 million seniors and people with disabilities saved an estimated $3.9 billion on prescription drugs, an increase from the 2012 savings, according to a report published by the U.S. Department of Health and Human Services.

Since the enactment of the Affordable Care Act, 7.9 million seniors and people with disabilities have saved $9.9 billion on , equivalent to $1,265 per beneficiary. In 2013, 4.3 million beneficiaries saved $3.9 billion, equivalent to $911 per beneficiary, which represented an increase from 2012 when 3.5 million beneficiaries saved $2.5 billion, representing average savings of $706 per beneficiary.

As well as savings on prescription drugs, use of has increased among those with Medicare, with an estimated 37.2 million Medicare beneficiaries (including 26.5 million with traditional Medicare) taking advantage of at least one preventive service with no cost sharing in 2013. This included more than four million people who took advantage of the Annual Wellness Visit in 2013. These figures reflect an increase from 2012 when an estimated 34.1 million people with Medicare, including 26.1 with traditional Medicare, received one or more preventive benefit.

"Thanks to the Affordable Care Act, we saw a stronger Medicare program in 2013," Kathleen Sebelius, U.S. Secretary of Health and Human Services, said in a statement. "Seniors are saving billions of dollars on their needed medications and continuing to enjoy benefits that will lead to healthier lives and lower costs in the long run."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

12 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.